Objectives
After participating in this educational activity, attendees should be able to:
1|Explain the purpose, scope, and regulatory role of USP <795>.
2|Differentiate key requirements (personnel, facilities, documentation, BUDs).
3|Apply USP <795> standards to real-world compounding scenarios.
Presenter(s):
Madalyn Dankocsik, PharmD
PGY1 Pharmacy Resident
Baystate Medical Center
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
|---|---|---|---|
| Madalyn Dankocsik, PharmD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Session date:
04/20/2026 - 2:00pm to 3:00pm EDT
Location:
Hybrid - Baystate Medical Center & Webinar
759 Chestnut Street
Springfield, MA
01199
United States
See map: Google Maps
Add to calendar:
- 1.00 ACPE Contact Hours
- 1.00 ACPE Technician contact hours
Facebook
X
LinkedIn
Forward